/
AFN Android App
DOWNLOAD THE AFN Android App
Get
AFN iOS App
DOWNLOAD THE AFN iOS App
Get
Perplexing status of mail-order abortion, during Trump’s second term, twists again

Perplexing status of mail-order abortion, during Trump’s second term, twists again


Perplexing status of mail-order abortion, during Trump’s second term, twists again

The Trump administration’s perplexing unwillingness to reinstate guardrails on abortion drugs took another disappointing turn this week.

President Donald Trump on Tuesday withdrew his nomination of Dr. Heidi Overton to lead the Food and Drug Administration.

Lankford, James (R-Oklahoma) Lankford

The position became open with the resignation of former FDA Commissioner Marty Makary in May.

Overton’s nomination was withdrawn the night before she was scheduled to appear before the Senate Health, Education, Labor and Pensions Committee.

It’s not that Overton isn’t pro-life. She has received endorsements from the pro-life community. As a former chief policy officer at America First Policy Institute, she authored briefs opposing expanded access to abortion pills and advocating for stricter FDA regulations on chemical abortion.

Some anti-abortion Republican senators and organizations weren't satisfied with Overton simply expressing opposition to relaxed abortion-pill restrictions. They wanted a commitment from the Trump administration that it would actually restore those restrictions, such as the requirement of an in-person doctor visit before the drugs could be prescribed. These restrictions were in place during Trump’s first term but were removed during the Biden administration. They’re still in place.

“Pro-life Senators sought final assurances from the Administration regarding the Administration's commitment to life issues,” Senator Bill Cassidy (R-Louisiana) said.

“The previous Trump administration did not allow mail-order abortion to be able to go out without prescription, without any verification, without actually seeing a doctor. There were lots of limitations in that. The Biden administration took all of that away. This Trump administration still has the Biden-era rules for chemical abortion,” Senator James Lankford (R-Oklahoma) said on “Washington Watch” Wednesday.

The ease of access to chemical abortion has been front and center for many life advocates.

Ultimately, the administration’s decision to withdraw Overton’s was made because of her involvement in decisions to change the childhood vaccination time period, Lankford told show host Jody Hice.

Cassidy, during Overton’s September nomination hearing, expressed concerns with her support of Trump’s executive order overhauling the childhood vaccine schedule.

“It wasn't asking children to be unvaccinated. It was changing the order and the structure of vaccinations as well. Apparently, some people disagreed with that, and they were upset about that, and so they were withholding a vote on it,” Lankford said.

As FDA commissioner, Overton would have had the authority to restore restrictions to mail-order abortion drugs.

That alone made her a target for Democrat opposition which means she was facing pushback from both parties.

Cassidy said “productive conversations” about Overton led him to believe she would have passed out of committee and would have ultimately passed a full Senate vote.

“Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” he wrote.